from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0443/-

LFCtreatmentdescriptionclass of inhibitor

1.123

Amikacinug/mL Amikacintranslation

0.580

Cap5-10ug/mL Capreomycintranslation

0.619

Rox10-50 ug/mL Roxithromycintranslation

-0.027

SM2-5 ug/mL Streptomycintranslation

1.281

Tet5-10 ug/mL Tetracyclinetranslation

-0.888

Rif0.2-5ug/mL Rifampicintranscription

-0.698

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.464

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.218

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.285

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.827

Clofazimine10-13 ug/mL Clofaziminerespiration

0.065

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.239

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.625

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.535

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.042

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.757

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.567

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.766

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.798

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.893

KCN5-20 ug/mL Potassium cyaniderespiration

1.522

NaN30.2-2 mM Sodium aziderespiration

-1.423

Nigericin50 uM Nigericinrespiration

0.265

TRC10-150 ug/mL Triclosanrespiration

-1.208

TRZ10-25 ug/mL Thioridazinerespiration

-0.080

Valinomycin0.5-10 uM Valinomycinrespiration

-0.366

ZnSO42 mM ZnSO4respiration

-0.635

menadione6-10 ug/mL Menadionerespiration

-0.581

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.342

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.440

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.051

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.696

NRP_1Non-replicating persistence stage 1dosRassociated

-0.388

Amp0.2mg/mL AmpicillincellWall

-0.197

Cephalexin20-100 ug/mL CephalexincellWall

-0.273

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.358

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.505

EMB10-20 ug/mL EthambutolcellWall

0.188

Eta12-40 ug/mL EthionamidecellWall

0.012

INH0.2-0.4 ug/mL IsoniazidcellWall

0.283

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.358

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.597

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.636

BZA0.12 mg/mL BenzamidearomaticAmides

0.852

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.973

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-1.322

H2O24 mM hydrogen peroxideDNAdamaging

0.104

Levo10 ug/mL LevofloxacinDNAdamaging

-0.792

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.388

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.536

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.587

UVUV-irradiationDNAdamaging

-0.132

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.378

Antimycin12.5-50 ug/mL Antimycin A?

-0.449

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.173

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.020

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.856

PA8240.2-2 ug/mL PA-824?

1.549

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.446

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.034

Verapamil50 uM Verapamil?

-0.544

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.495

methoxatin10-20 ug/mL Methoxatin?